Backhouse J L, Hudson B J, Hamilton P A, Nesteroff S I
Department of Clinical Microbiology, Institute of Clinical Pathology and Medical Research, Westmead, New South Wales, Australia.
Am J Trop Med Hyg. 1998 Sep;59(3):388-92. doi: 10.4269/ajtmh.1998.59.388.
The endemic treponematosis yaws remains a significant cause of morbidity in many tropical countries, despite mass treatment campaigns to eradicate it. An outbreak of yaws in Marup village on Karkar Island, Papua New Guinea in 1988 provided an opportunity to monitor the outcome of treatment with penicillin over an extended period. Thirty-nine children with clinical yaws (6% of 632 examined) were monitored clinically and serologically, for nearly two years after mass treatment of all villagers with the World Health Organization recommended dosages of benzathine penicillin. Lesions resolved within one month of treatment in all but four (10%) children, three of whom were initially successfully retreated. Before treatment, the Venereal Disease Research Laboratory (VDRL) test result was reactive in 67% of the children and treponema-specific IgM antibody test results were reactive in 41%. Within six months of treatment, of those reactive, the VDRL titer decreased significantly in 25 (96%) of 26 and IgM antibody test results became negative in 13 (81%) of 16 children. However, by the end of follow-up, 11 (28%) of the 39 children had developed clinical and/or serologic evidence of relapse. In these children, response to further treatment was slow and, in three, evidence of active infection persisted or recurred, despite repeated courses. Exogenous reinfection was unlikely in this isolated community, in which the occurrence of yaws was closely monitored after universal treatment. Treatment failure was most likely to have been due to reduced susceptibility to penicillin of Treponema pallidum subsp. pertenue.
尽管开展了大规模治疗运动以根除地方性密螺旋体病雅司病,但在许多热带国家,它仍是发病的一个重要原因。1988年,巴布亚新几内亚卡尔卡尔岛马鲁普村爆发了雅司病,这提供了一个机会来长期监测青霉素治疗的效果。在用世界卫生组织推荐剂量的苄星青霉素对所有村民进行大规模治疗后,对39名患有临床雅司病的儿童(占632名接受检查儿童的6%)进行了近两年的临床和血清学监测。除4名儿童(10%)外,所有儿童的皮损在治疗后1个月内均消退,其中3名儿童最初接受再次治疗取得成功。治疗前,67%的儿童性病研究实验室(VDRL)试验结果呈阳性,41%的儿童梅毒螺旋体特异性IgM抗体试验结果呈阳性。治疗后6个月内,在这些呈阳性反应的儿童中,26名儿童中有25名(96%)的VDRL滴度显著下降,16名儿童中有13名(81%)的IgM抗体试验结果转为阴性。然而,到随访结束时,39名儿童中有11名(28%)出现了复发的临床和/或血清学证据。在这些儿童中,对进一步治疗的反应缓慢,有3名儿童尽管多次接受治疗,仍有活动性感染的证据持续存在或复发。在这个与世隔绝的社区中,外源性再感染的可能性不大,因为在普遍治疗后对雅司病的发生进行了密切监测。治疗失败最可能是由于苍白密螺旋体亚种 pertenue对青霉素的敏感性降低所致。